-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Freeline Therapeutics Holdings plc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2020 to Q1 2023.
- Freeline Therapeutics Holdings plc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$18.4M, a 30.6% increase year-over-year.
- Freeline Therapeutics Holdings plc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$78.2M, a 27.3% increase from 2021.
- Freeline Therapeutics Holdings plc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$108M, a 13.3% decline from 2020.
- Freeline Therapeutics Holdings plc annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$95M, a 81.5% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)